SCHEMBL21738231

SCHEMBL21738231

Cc1cc2c(cc1Cl)CN(C)C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.43
PRF1 P14222 3/20 0.38
DDB1 Q16531 2/20 0.37
CRBN Q96SW2 2/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
DRD3 P35462 1/20 0.34
GABRA1 P14867 3/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA2 P47869 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21610984 0.93 LRRK2 (0.46) LRRK2PRF1DDB1CRBNKMT2A
SCHEMBL25453057 0.85 DDB1 (0.40) LRRK2PRF1DDB1CRBNKMT2A
SCHEMBL26767584 0.81 ESR1 (0.40) LRRK2PRF1CRBNGABRA1GABRG2
SCHEMBL21738235 0.81 LRRK2 (0.42) LRRK2PRF1DDB1CRBNKMT2A
SCHEMBL21954898 0.78 LRRK2 (0.41) LRRK2PRF1DDB1CRBNKMT2A
SCHEMBL17339035 0.78 MEN1 (0.54) LRRK2KMT2AMEN1GABRA1GABRG2
SCHEMBL14993043 0.77 LRRK2 (0.45) LRRK2PRF1DDB1CRBNKMT2A
SCHEMBL27308798 0.76 ALDH1A1 (0.39) LRRK2DDB1CRBNKMT2AMEN1
SCHEMBL23805755 0.76 LRRK2 (0.44) LRRK2DDB1CRBNKMT2AMEN1
SCHEMBL21610992 0.76 MEN1 (0.55) LRRK2PRF1KMT2AMEN1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4265608-A1 BENZOHETEROCYCLE SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) 2023-10-25 EP disclosed
WO-2020036437-A1 SUBSTITUTED HETEROARYL DERIVATIVE, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASES WHICH CONTAINS SAME AS ACTIVE INGREDIENT 재단법인 대구경북첨단의료산업진흥재단 2020-02-20 WO disclosed